Predict your next investment

Venture Capital
pac.vc

See what CB Insights has to offer

Investments

2

About Pacific Health Ventures

Pacific Health Ventures is a healthcare venture capital firm in Silicon Valley focused on early stage B2B health tech.

Pacific Health Ventures Headquarter Location

2710 Sand Hill Road

Menlo Park, California, 94025,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Pacific Health Ventures News

Hikma Ventures leads Series A financing for development of Winterlight Labs' AI vocal technology to detect central nervous system disorders and track efficacy of treatments

Nov 19, 2019

Hikma Ventures leads Series A financing for development of Winterlight Labs' AI vocal technology to detect central nervous system disorders and track efficacy of treatments LONDON, November 18, 2019-- Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's / BB+ S&P, both stable) announces that its venture capital arm, Hikma Ventures has led a CAD 5.6 million oversubscribed round of financing for Winterlight Labs Inc. with participation from First Star Ventures, Pacific Health Ventures, existing investor Grey Sky Venture Partners and other investors. Toronto-based Winterlight Labs Inc. is developing a proprietary Artificial Intelligence (AI) technology that melds computational linguistics, cognitive neuroscience, and machine learning to help healthcare professionals assess and analyse patients' cognitive health – including memory, thinking and reasoning – from vocal markers captured in short snippets of speech on a tablet computer. Using a one-minute sample of a patient's natural speech, Winterlight's novel approach can quickly and accurately detect various cognitive and mental disorders, such as dementia and aphasia amongst others, and then monitor the efficacy of treatments. Lana Ghanem, Managing Director of Hikma Ventures, said, "We are very excited to enter into the field of vocal diagnostics by leading the investment in Winterlight Labs. We recognise the global potential of voice analysis for the diagnosis, monitoring and ongoing treatment of various diseases and look forward to working with the team and our co-investors to help advance the technology and expand disease areas and geographies covered, especially in the Middle East and North Africa." Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals. Its priority is to identify and invest in emerging companies in the digital health space globally that have the potential to enhance Hikma's market intelligence and future pipeline. "We are happy to have Hikma Ventures and other investors join Winterlight Labs in our mission to improve the lives of people with dementia and other psychiatric illnesses," commented Liam Kaufman, Co-founder and CEO of Winterlight Labs. "The technology our team is creating will reshape the way healthcare systems track, screen for and assess the effectiveness of treatments for various central nervous system diseases." Winterlight will be using the proceeds of this financing to extend its technology to additional indications, such as schizophrenia and multiple sclerosis, as well as additional languages. "Our ultimate goal is to help patients get better sooner by objectively measuring response to therapy in the real world through speech," continued Kaufman. About Hikma Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we're a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,400 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit www.hikma.com. About Hikma Ventures Founded in August 2015, Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals. Hikma Ventures invests in global start-ups where Hikma's expertise can accelerate revenue growth and enhance value creation by providing ventures with access to the resources of a multinational pharmaceutical company. For more information, please visit www.hikmaventures.com. About Winterlight Labs Inc. Winterlight has developed a tablet-based assessment that is fast, objective, and stress-free. By analysing speech alone, the technology can detect cognitive impairment associated with dementia and mental illness as track the efficacy of related treatments. The Winterlight assessment can be used in life science research, senior care and clinical settings. For more information, please visit https://winterlightlabs.com/.

Pacific Health Ventures Investments

2 Investments

Pacific Health Ventures has made 2 investments. Their latest investment was in SafelyYou as part of their Series A on September 9, 2021.

CBI Logo

Pacific Health Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/16/2021

Series A

SafelyYou

$19.5M

Yes

1

11/18/2019

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/16/2021

11/18/2019

Round

Series A

Series A

Company

SafelyYou

Subscribe to see more

Amount

$19.5M

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

1

10

Pacific Health Ventures Team

2 Team Members

Pacific Health Ventures has 2 team members, including current Managing Director, Chris Furmanski.

Name

Work History

Title

Status

Chris Furmanski

Managing Director

Current

Jason Ash

Chief Executive Officer

Former

Name

Chris Furmanski

Jason Ash

Work History

Title

Managing Director

Chief Executive Officer

Status

Current

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.